Skip to main content
TipRanks
Go Ultimate75% OFF

Serina Therapeutics (SER) Income Statement

261 Followers

Serina Therapeutics Income Statement

Last quarter (Q3 2026), Serina Therapeutics's total revenue was $125.00K. In Q3, Serina Therapeutics's net income was $-7.91M. See Serina Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Mar 23Dec 21
$ 0.00$ 56.00K$ 3.15M$ 500.00K$ 3.46M
$ 0.00$ -138.00K$ 3.06M$ 500.00K$ -333.84K
$ 24.02M$ 16.91M$ 6.19M$ 2.77M$ 1.30M
Depreciation and Amortization$ 73.00K$ 194.00K$ 90.00K$ 61.27K$ 33.37K
$ -18.91M$ -10.49M$ 5.92M$ -2.60M$ -1.23M
$ -24.02M$ -17.05M$ -3.13M$ -2.27M$ -1.63M
$ 4.83M$ 5.84M$ 8.40M$ -411.74K$ 366.81K
$ -19.20M$ -11.21M$ 5.27M$ -2.68M$ -1.26M
$ -19.18M$ -11.14M$ 5.27M$ -2.68M$ -1.26M
Per Share Metrics
Basic EPS$ -1.91$ -1.51$ 0.63$ -2.49$ -0.59
Diluted EPS$ -1.91$ -1.51$ 0.63$ -2.49$ -0.59
Weighted Average Shares Outstanding10.19M7.36M8.41M1.08M1.08M
Weighted Average Shares Outstanding (Diluted)10.19M7.36M8.41M1.08M1.08M

Currency in USD

Serina Therapeutics Earnings and Revenue History

-24M-12M012M-24000 %-12000 %0 %12000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin